Listed Giants and Top 100 Enterprises Unveil New Strategies at the 5th Future Healthcare 100 Conference

On April 17, the second day of the “Top 100 Future Healthcare Companies” conference continued in Wujiang, Suzhou. The event was organized by VCBeat, co-hosted by the People’s Government of Wujiang District, Suzhou City, and the Guangdong Zhong Nanshan Medical Foundation, with support from Suzhou Wujiang Dongfang State-owned Capital Investment & Operation Co., Ltd., and Alibaba Health as the exclusive strategic partner.

VB100 Strategic Summit Site

In Wujiang this April, the warm spring sun shone as brightly as ever, and the VB100 Strategic Summit drew crowds just as it had in previous years. Many attendees arrived early to take their seats, and every conference hall remained bustling with people.

VB100 Strategic Summit Venue

The VB100 Strategic Summit was divided into morning and afternoon sessions. The morning session, themed “Leaders’ Perspective: Strategic Announcements by Listed Companies,” featured guests from KingMed Diagnostics, New Horizon Health, Donghua Software, BOE, GE Healthcare, Genetron Health, and Huarong Rongde Asset Management. From a leadership perspective, they jointly explored the key element models of corporate growth. The afternoon session, themed “Computing the Future: The Path to Innovation for Top 100 Enterprises,” featured guests from Changling Capital, Kunyuan Gene, DXY, Haodf Online, Xinyi International, Shanzhen, Miao Health, and Meivie Dental, who shared on-site their new technologies, new models, new scenarios, and new ecosystems in industrial innovation practices.

Xie Jiangtao, COO and Vice President of KingMed Diagnostics, delivered a speech titled “Exploration and Practice of KingMed Diagnostics 4.0.” He noted that, in response to major trends and challenges in the healthcare sector, KingMed Diagnostics has leveraged its advantages in large-scale samples, big data, extensive networks, and robust platforms to fully launch its digital transformation. By driving healthcare equalization through technological innovation, the company aims to make medical and health services more precise, convenient, and inclusive. He further stated that “Medical Laboratory Services 4.0” centers on disease diagnosis and health services, achieving end-to-end intelligent laboratory services, fostering integrated innovation between biomedicine and next-generation information technologies, and building an open ecosystem platform to serve the entire healthcare industry chain.

Xie Jiangtao, COO and Vice President of KingMed Diagnostics

Zhu Yeqing, Executive Director and CEO of New Horizon Health, delivered a speech titled “How Far Is the Vast Frontier of Early Cancer Screening?” He pointed out that there are three core elements defining early cancer screening products: clear clinical guidance significance, simple methods for confirmatory diagnosis, and feasible clinical intervention measures. He also noted that promoting early cancer screening in China remains a long and arduous task, with the most urgent priority being to enhance public awareness of early cancer screening.

Zhu Yeqing, Executive Director and CEO of New Horizon Health

Yan Hua, Vice President of GE Healthcare China and Chief Marketing Officer, delivered a keynote speech titled “China’s Digital + Healthcare Innovation Prescription: Comprehensive Localization, Digital Empowerment, and Win-Win Cooperation.” She shared GE Healthcare’s efforts in building digital healthcare through intelligent devices, intelligent management, and intelligent clinical solutions. She highlighted GE Healthcare’s China strategy, which focuses on comprehensive localization, digital empowerment, and win-win cooperation. The company is committed to collaborating extensively with partners both within and outside the industry across multiple dimensions—including technological innovation, scenario-based innovation, and cross-sector innovation—to jointly create a smart healthcare ecosystem.

Yan Hua, Vice President of GE Healthcare China and Chief Marketing Officer

Zhang Wei, Co-CEO of BOE’s Smart Healthcare Business Group, delivered a speech titled “A New Ecosystem for Health Management in the IoT Era.” He introduced emerging trends in the smart healthcare ecosystem and stated that, to address these current trends, BOE has established a “4 Zero 4D” digital-driven digital hospital platform.

Zhang Wei, Co-CEO of BOE's Smart Healthcare Business Group

Wen Heng, Vice President of DHC Software Co., Ltd. and Chief Consultant at DHC Medical Information Technology, delivered a keynote speech titled “HOS: Building a New Generation of Smart Hospitals Through Digital Twins.” He pointed out that the national 14th Five-Year Plan has brought a series of new impacts to the informatization construction of public hospitals and highlighted the potential for improvement in current management practices at these institutions. Furthermore, Wen introduced the Hospital Operating System (HOS), developed by DHC Medical Information Technology based on the concept of digital twins, and outlined its advantages in supporting clients’ smart hospital initiatives.

Wen Heng, Vice President of DHC Software Co., Ltd. and Chief Consultant of DHC Medical Information

Genetron Health’s CFO, Xu Ce, delivered a speech titled “Original Technologies Empowering the Entire Cycle of Precision Cancer Diagnosis and Treatment.” He pointed out that the integration of gene technology with multi-omics and multidisciplinary approaches has brought about a qualitative shift in cancer diagnosis and treatment models, ushering in significant development opportunities for precision oncology in China. Meanwhile, Xu Ce introduced that Genetron Health boasts a team of technological innovation experts and cutting-edge technologies, and has tailored its products and services to address the evolving landscape of cancer care, offering diverse solutions.

Xu Ce, CFO of Genetron Health

Zhu Min, General Manager of the Medical Finance Department at Huarong Rongde Asset Management Co., Ltd., delivered a speech titled “The Future Is Here: Exploring How Comprehensive Financial Services Empower the Digital Transformation and Upgrading of the Healthcare Industry.” She pointed out that digitalization has become a new engine for the development of the healthcare industry. Unlike previous stages characterized by informatization and internet integration, healthcare digitalization is now embedded in various core segments of the industry through multiple approaches. Data has emerged as a foundational resource element, reshaping the industrial value chain, fostering new business models, and driving profound transformations in organizational structures and corporate culture.

Faced with new species of digitally transformed healthcare enterprises, we cannot rely on traditional cognitive frameworks and valuation systems. Instead, a new equity investment logic will emerge, centered on data-driven business value and spanning various specialized sectors. The integration of industry and digital technology will inevitably drive the convergence of industry and finance. Future financial services will no longer focus exclusively on large corporations but will instead establish a new service system centered around highly mature, digitally versatile enterprises. Digital transformation will also spur the digital evolution of financial investment institutions themselves, encouraging investment teams to build cross-disciplinary, composite capabilities on top of their professional expertise. Huarong Rongde’s vision is to become strategic partners with digital healthcare companies, peer institutions, and third-party service platforms, thereby creating a new ecosystem for the integrated development of industry and finance through digitalization.

Zhu Min, General Manager of the Medical Finance Department at Huarong Rongde Asset Management Co., Ltd.

Jiang Xiaodong, Managing Partner at Changling Capital, delivered a speech titled “Seeing Is Believing: Reimagining the Future of Healthcare Through Innovative Services.” He pointed out that while the current enthusiasm from the capital market has ushered healthcare startups into a period of accelerated growth opportunities, healthcare remains, at its core, a slow-moving industry. Capital markets inevitably experience cycles—highs and lows, fast and slow paces, heat and coolness—but the fundamental demand for healthcare cannot be altered by capital flows. Entrepreneurs and investors alike must adopt a long-term perspective and remain steadfast, steering clear of fleeting trends and placing their faith in the power of compounding returns. Jiang Xiaodong stated that Changling Capital aims to stand alongside entrepreneurs, dedicating ten years to honing a single sword, so as to build the next generation of healthcare enterprises.

Jiang Xiaodong, Managing Partner of Changling Capital

Zhang Jiangli, Founder and CEO of Genetron Health, delivered a speech titled “How to Build Future Competitiveness for Cancer Early Screening Products.” He stated that cancer has become a major public health issue seriously threatening the health of the Chinese population. Currently, the country is vigorously promoting cancer screening, achieving significant results in prevention and control, but there is still a long way to go. Meanwhile, he introduced that Genetron Health is developing “First-in-Class” products and technologies for early cancer detection, providing differentiated products and services for various scenarios. By focusing on grassroots levels as the entry point and primary application scenario for cancer screening, the company aims to empower public welfare initiatives in early cancer detection.

Zhang Jiangli, Founder and CEO of Kunyuan Biotech

Li Tiantian, Founder and Chairman of DXY, delivered a speech titled “New Trends in the Digital Marketing Transformation of the Pharmaceutical Industry in the Post-Pandemic Era.” He noted that the key to digital innovation in the healthcare sector lies in maintaining professional credibility, fostering collaborative integration, and adhering to a user-value-centric unified objective. Given the complex ecosystem, high professional barriers, and stringent regulatory principles characteristic of the healthcare industry, it is difficult for any single enterprise to close the loop across the entire industry through solitary efforts. Li Tiantian explained that DXY has expanded its upstream ecosystem with a “user-centric” approach by deepening supply-side capabilities through collaborative co-construction, thereby establishing supply-side advantages and truly achieving the goal of “aggregating professional expertise to deliver reliable products.”

Li Tiantian, Founder and Chairman of DXY

Wang Hang, Founder and CEO of Haodf Online, delivered a speech titled “Internet Healthcare Accelerates Its Shift Toward ‘Patient-Centered’ Care.” He stated that the pandemic has propelled the industry into its third phase of rapid development. Third-party platforms and public hospitals will move toward collaboration, while private offline hospitals will increasingly focus on consumer-oriented healthcare. Online services for serious medical conditions will accelerate, pharmaceuticals and medical services will gradually be decoupled, and the industry will enter a period of standardized development. Enhancing service quality with a patient-centered approach remains a significant challenge, yet it represents the most promising future worth anticipating.

Wang Hang, Founder and CEO of Haodf Online

Wang Zhao, Vice President of Senyi International and General Manager of the Strategic Demonstration Zone, delivered a speech titled “Network-Cloud-Terminal Collaboration: Realizing Value-Based Services in Smart Healthcare.” He noted that achieving supply-side reform requires robust medical collaboration capabilities. Senyi International’s business model integrates its network (SenyiNet), cloud (SenyiBrain), and terminal (SenyiTerminal) solutions to continuously empower governments, hospitals, and physicians through its smart healthcare cloud platform. By partnering with stakeholders, the company jointly establishes multiple application scenarios that deliver value-based services to patients, while also developing integrated pharmaceutical and insurance services around specific diseases to deeply connect various parties. Wang Zhao stated that Senyi International’s mission is to make no disease difficult to treat through intelligent telemedicine services.

Wang Zhao, Vice President of Heart Medical International and General Manager of the Strategic Demonstration Zone

Wu Hongxing, Founder and CEO of Shanzhen, delivered a speech titled “Reflections and Practices in the Parental Health Industry.” He stated that future elderly care models will shift from “children personally providing care” to “achieving elderly care through purchasing services.” Wu Hongxing pointed out that the main battlefield of the broader health industry is the elderly population, not the young. The fundamental solution lies in transitioning from passive treatment to active prevention: “Only by stepping beyond the confines of medical treatment can we better address healthcare challenges; only by deeply engaging with supply can we create new supply.”

Wu Hongxing, Founder and CEO of Shanzhen

Miao Health CEO Kong Fei delivered a speech titled “How Digital Health Management Empowers Insurance Upgrading in the AIoT Era.” He noted that in the AIoT era, enhancing health management services relies on the integration of “AI + human expertise” and “online + offline” models. Miao Health’s collaborations in insurance scenarios primarily focus on helping insurers build digital middle platforms to achieve deep integration of “insurance + health management.” This empowers end-to-end insurance upgrades through innovative insurance product design, marketing and health services, intelligent underwriting and claims processing, personalized health plans, precision medical service arrangements, and offline health management stores. As a health management organization, creating value for users should always take precedence over the company’s commercial interests.

Miao Health CEO Kong Fei

Zhu Liya, Founding Partner and CEO of Meiwei Dental Care, appeared as the final keynote speaker at the VB100 Strategic Summit. She highlighted that Meiwei Dental Care is China’s first dental healthcare enterprise to develop under the DSO (Dental Support Organization) model. She stated that Meiwei’s informatics solutions represent the accumulation of operational and management expertise in the dental chain industry, integrated with an information management model tailored to the characteristics of the internet. At the core of Meiwei’s informatization initiative is a patient-centered and care-centered approach, aimed at building an intelligent health ecosystem platform and pioneering new models of diagnosis and treatment. In the future, “technology” + “healthcare” will become a defining hallmark of Meiwei, as the company continues to delve deeply into the dental sector and embrace the new era of digital intelligence.

Zhu Liya, Founding Partner and CEO of Meiwei Dental Healthcare

In addition, parallel sessions including the Pharmaceutical Digital Marketing Forum, the High-Value Consumables Development Forum, the Internet Hospital Innovation Forum, the Data Intelligence and Payment Innovation Forum, the Transformation of Scientific Achievements and Industrial Development Forum, and the Assisted Reproductive Technology Industry Development Forum were also held at the 5th VB100 Forum.

Over the past five years, the Future Healthcare 100 Forum has evolved into a platform where medical innovators share both their achievements and regrets from exploratory practices, and even more so, an ecosystem where new friends and old acquaintances jointly discuss the future of healthcare. The imperfections of healthcare have long troubled many people. The value of innovators to our era lies in opening up new pathways to reach better medical solutions, or in disproving the feasibility of certain optimization hypotheses. The guests attending today’s VB100 Strategic Summit come from diverse fields such as medical services, medical devices, pharmaceutical informatics, and internet healthcare. While their work may be based within or outside hospitals, and their service scenarios span every stage of the disease course, they are united in their pursuit of the optimal medical solution under objective conditions. We firmly believe that the “calculation of life” may change everyone’s life trajectory in the future.